Ovarian/Breast Disorders Lecture Flashcards
- follicle
- maturing follicle
- ovulation
- corpus luteum
Whats next (if not pregnant)
Degeneration of corpus luteum
When does estradiol peak?
Right before ovulation
When do lutenizing hormone (LH) and follicle stimulating hormone (FSH) peak?
During ovulation
When is Progesterone highest?
Luteal phase
When does body temperature increase?
Second half of ovulation into luteal phase
Adnexal refers to the…
ovary
Follicular cyst
most common ovarian cyst
Usually not symptomatic
Usually resolve spontaneously
Result from failure of ovulation
Follicular cyst
Cysts that occur after ovulation
Thin-walled, unilocular
Corpus luteum cyst
Cysts in pregnancy or molar gestation
*bilateral functional cyst greater than 3 cm
Theca-lutein
What type of cyst can sometimes occur with endometriosis
Hemorrhagic cyst
Management of fluid filled cysts
Monitor with period ultrasound
Management of non fluid filled cysts
Remove it (laparoscopic)
If cyst greater than 6 cm, what might happen?
TORSION! must remove cyst!
How can you prevent ovarian cysts?
How can you tx pain?
Prevent with OCPs
Tx pain with NSAIDs
Diagnose clinically if 2 of 3 conditions:
Oligo or amenorrhea and anovulation
Hyperandrogenism
Obesity (50%)
Hirsutism (30-75%)
Ultrasound: evidence of polycystic ovaries (not always)
PCOS
- Most common cause of infertility in women
- Insulin resistance (higher risk of diabetes)
- Unopposed estrogen
PCOS
- OCPs tx unopposed estrogens and hirsutism
- can cycle with progesterone
- metformin for insulin resistance (may improve infertility)
- clomiphene citrate for infertility
PCOS tx
What part of the pituitary produces FSH and LH?
Anterior
Granulosa cells (which act as neg feedback to ant. pituitary ) Development of oocytes
This is done by FSH or LH?
FSH
Theca cells which produce androgens
This is done by FSH or LH?
LH
Never progress to luteal phase- creates exogenous estrogen
PCOS
Abnormal feedback regulation promotes more LH than FSH
PCOS
(insufficient FSH to stimulate granulosa cells
Enlarging ovarian mass with a solid component or change in character, especially in a postmenopausal woman
What is the management?
REMOVE IT
Is screening for ovarian cancer (ultrasound or CA-125) recommended?
NO
Where do 85-90% of ovarian cancers originate?
Epithelium
young women with ovarian tumors are typically this kind…
germ cell tumors
appear in connective tissue cells of the ovaries that produce estrogen and progesterone
stromal carcinoma tumors
rare, low grade malignancies, produce hormones
Oral contraceptives
More than 1 full term pregnancy before age 35
Breast feeding
Tubal ligation
protective against ovarian cancer
risk peaks 65-75 yo
The most lethal gynecologic malignancy- “silent killer”
Ovarian cancer
Most women present with late stage disease:
Abdominal pain/bloating
Early satiety
Urinary urgency/frequency
Ovarian cancer
Transvaginal Ultrasound
Laproscopic Evaluation
used in dx of ovarian cancer
most common breast complaint in primary care
breast pain
Associated with hormonal changes, usually 1 week prior to onset of menses (due to proliferation of normal glandular breast tissue)
Cyclic breast pain
Spontaneous Unilateral Confined to one duct Bloody Clear, yellow, white, dark green Associated with a mass Women age >40
Pathologic nipple discharge
Discharge only with compression
Often bilateral
Multiple ducts involved
Fluid may be clear, yellow, white or dark green
Benign nipple discharge
physiologic nipple discharge
Usually bilateral milky nipple discharge involving multiple ducts
Caused by hyperprolactinemia
galactorrhea
Solid, firm & mobile mass- “rolled to an edge”
typically in young women
Fibroadenoma
Fluid-filled mass, compressible or ballotable
Premenopausal and perimenopausal women
Cyst
Diffuse, tender, does not form discrete or well-defined mass
Associated with breast pain, cyclic, premenopausal
PE: breast tissue frequently nodular
Fibrocystic changes
Gold standard of dx breast cancer
biopsy
Milk retention cyst in breastfeeding women
Galactocele
Can develop after trauma, surgery , radiation- diff. to distinguish
*seen in breast augmentation or reduction procedures
Fat necrosis
3 steps of assessing to diagnose or rule out breast cancer
- physical exam
- mammogram
- needle biopsy (fine needle aspiration or core needle biopsy)
Most common solid benign breast mass Well-defined, mobile solid mass Etiology unknown but hormonal relationship likely Most commonly found between ages 15-35 Definitive diagnosis: CNB or excision
Fibroadenoma
Localized, painful inflammation of breast associated with fever & malaise
Occurs in 2-10% of breastfeeding women
Usually due to breastfeeding problems
If left untreated – local abscess formation
PE: hard, red, tender, swollen area of 1 breast
Staph aureus
Treatment: dicloxacillin or clindamycin (MRSA)
Lactational mastitis
BRCA genes increase lifetime risk of breast cancer by…..
60-80%
- Eastern European heritage
- African American female diagnosed before age 35
- Test family members of any male diagnosed with breast cancer
- When a woman has had breast cancer in both breasts
- When multiple family members have had breast cancer or gynecologic cancers
- When a blood relative has had breast cancer before age 50
Test for BRCA
what type of aspiration can be used to confirm dx of breast cysts
fine needle aspiration
which is more invasive, fine needle or core needle?
CORE
Spontaneous Unilateral Confined to one duct Bloody Clear, yellow, white, dark green Associated with a mass Often NO Pain
pathologic breast issues
malignant have less discharge
Discharge only with compression Often bilateral Multiple ducts involved Fluid may be clear, yellow, white or dark green Often present with Pain
Benign breast issues
Often, the simplest way to determine whether a palpable mass is cystic or solid is to _______ the mass.
aspirate
ductal or lobular carcinoma (CIS)
+carcinoma in situ
invasive or non invasive?
non invasive
most common type of non invasive breast cancer
- non life threatening
- can increase risk of developing invasive cancer
ductal carcinoma in situ (DCIS)
(ductal= milk
in situ=in its original place)
lumpectomy only recurrence rate with DCIS
25%
down to 15% for lumpectomy plus radiation
infiltrating ductal carcinoma
most common breast cancer (this is the kind men get also)
70-80% all breast cancers
swelling of all or part of the breast skin irritation or dimpling breast pain nipple pain or the nipple turning inward redness, scaliness, thickening of the nipple or breast skin a nipple discharge other than milk Enlarged lymph in axilla
infiltrating ductal carcinoma
- Size of the tumor
- Whether the cancer has spread to lymph nodes, and if so, how many
- Whether the cancer has spread to other parts of the body
- ER/PR Her2/neu status
staging of breast cancer
Estrogen down regulator drug
Tamoxifen
Provider visit with exam every 3-6 months for first 3 years
Every 6-12 months for years 4 and 5
Every year post year 5
Yearly mammogram
Monitor for side effects of any medication
Yearly pelvic exams (some tx drugs increase unterine cancer risk)
Follow up guidelines for breast cancer
second most common type of breast cancer
tends to occur later in life (early 60s)
invasive lobular carcinoma (ILC)
rare
dx usually made w skin punch biopsy
*very invasive
*high mets rate
staging tests include: CXR CT of chest, abdomen, pelvis Bone scan Liver function test
inflammatory breast cancer
Collection of abnormal cells
- not a true cancer
- increased risk of dev. invasive CA later in life
- diagnosed b/f menopause
- usually diagnosed because of a biopsy performed for some other reason
- usually hormone receptor positive
lobular carcinoma in situ (LCIS)
- rare form of breast CA in which cancer cells collect in or around the nipple
- less than 5% of all breast CA cases
- 97% of patients also have DCIS or invasive CA somewhere else in the breast
- ave. age of diagnosis = 62
Paget’s disease
itching, tingling, and/or burning sensation
pain or sensitivity
scaling & thickening of the skin
yellowish or bloody d/c from the nipple
Paget’s disease
Lymph Nodes Muscle , Fatty Tissue and Skin Bones- ribs, spine, pelvis, & long bones arms /legs Bone Marrow Liver Lungs Brain
Most common sites of breast cancer metastasis